Dare Bioscience (DARE) Misses Q3 EPS by 55c

Dare Bioscience (NASDAQ: DARE) reported Q3 EPS of ($0.55). Revenue for the quarter came in at $41.69 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• L3Harris CEO steps down amid conduct review, shares drop
• Shein targets $26-27 billion valuation in Hong Kong IPO - report